The National List of Essential Medicines 2015 (NLEM) prepared by the Ministry of Health and Family Welfare has been included in the Drugs (Prices Control) Order, 2013 (DPCO 2013) as Revised Schedule � I replacing the Original Schedule � I on 10.03.2016. The Revised Schedule - I contains 376 medicines covering net 814 formulations/packs. The Government has so far fixed the ceiling prices of 540 formulations under Revised Schedule �I of DPCO 2013. The percentage wise reduction in the ceiling price with respect to the highest price is tabulated as follows:
| Percentage reduction with respect to Maximum Price | No. of scheduled formulations |
| 0<= 5% | 129 |
| 5<=10% | 74 |
| 10<=15% | 67 |
| 15<=20% | 68 |
| 20<=25% | 61 |
| 25<=30% | 42 |
| 30<=35% | 33 |
| 35<=40% | 18 |
| Above 40% | 48 |
| Total formulations in NLEM 2015 | 540 |
Further, the NLEM and hence Schedule I of DPCO 2013 do not define lifesaving medicines separately.
The fixation of ceiling prices/MRP has resulted in a total saving of Rs. 5117.74 crores to the public after implementation of DPCO, 2013.
Public Health being a State subject the primary responsibility to ensure the availability of medicines is that of respective State/UT Governments. Under National Health Mission (NHM) support is being provided to States/UTs for strengthening of their healthcare facilities including support for NHM Free Drugs Service for provision of essential medicines free of cost in public health facilities based on the Programme Implementation Plans submitted by the States/UTs.
More from miscw.com
Trial Master File Reference Model Group Officially Affiliates with CDISC- China Hemp, Cannabis and CBD Importing and Exporting Regulatory Report 2021 – ResearchAndMarkets.com
Infobip APAC Study: Hybrid CX is Key to Boosting Customer Loyalty in Hong Kong- GVE, a Developer of a Central Bank Digital Currency Platform Has Increased Its Valuation to 224 Billion Yen
